TY - JOUR
T1 - A simple validated RP-HPLC bioanalytical method for the quantitative determination of a novel valproic acid arylamide derivative in rat hepatic microsomes
AU - Silva-Trujillo, Arianna
AU - Correa-Basurto, José
AU - Romero-Castro, Aurelio
AU - Albores, Arnulfo
AU - Mendieta-Wejebe, Jessica Elena
N1 - Publisher Copyright:
© 2014 John Wiley & Sons, Ltd.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - A simple and specific bioanalytical method based on reversed-phase high-performance liquid chromatography (RP-HPLC) coupled with ultraviolet detection was developed and validated for the determination of a novel valproic acid arylamide, N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) in rat hepatic microsomes (a subcellular fraction containing phase I enzymes, especially cytochrome P450). The chromatographic separation was achieved using a reversed-phase Zorbax SB-C18 column and a mobile phase of acetic acid in water (0.2% v/v) and acetonitrile (40:60v/v) with a flow rate of 0.5mL/min. The calibration curve was linear over the range of 882-7060ng/mL (r2=0.9987), and the lower limit of quantification and the lower limit of determination were found to be 882 and 127.99ng/mL, respectively. The method was validated with excellent sensitivity, and intra-day accuracy and precision varied from 93.79 to 93.12%, and from 2.12 to 4.36%, respectively. The inter-day accuracy and precision ranged from 93.29 to 97.30% and from 0.68 to 3.60%, respectively. The recovery of HO-AAVPA was measured between 91.36 and 97.98%. The assay was successfully applied to the analysis of kinetic metabolism and pharmacokinetic parameters in vitro by a substrate depletion approach.
AB - A simple and specific bioanalytical method based on reversed-phase high-performance liquid chromatography (RP-HPLC) coupled with ultraviolet detection was developed and validated for the determination of a novel valproic acid arylamide, N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) in rat hepatic microsomes (a subcellular fraction containing phase I enzymes, especially cytochrome P450). The chromatographic separation was achieved using a reversed-phase Zorbax SB-C18 column and a mobile phase of acetic acid in water (0.2% v/v) and acetonitrile (40:60v/v) with a flow rate of 0.5mL/min. The calibration curve was linear over the range of 882-7060ng/mL (r2=0.9987), and the lower limit of quantification and the lower limit of determination were found to be 882 and 127.99ng/mL, respectively. The method was validated with excellent sensitivity, and intra-day accuracy and precision varied from 93.79 to 93.12%, and from 2.12 to 4.36%, respectively. The inter-day accuracy and precision ranged from 93.29 to 97.30% and from 0.68 to 3.60%, respectively. The recovery of HO-AAVPA was measured between 91.36 and 97.98%. The assay was successfully applied to the analysis of kinetic metabolism and pharmacokinetic parameters in vitro by a substrate depletion approach.
KW - CYP
KW - Metabolic stability
KW - Microsomes
KW - RP-HPLC
KW - Validation
UR - http://www.scopus.com/inward/record.url?scp=84925324742&partnerID=8YFLogxK
U2 - 10.1002/bmc.3307
DO - 10.1002/bmc.3307
M3 - Artículo
C2 - 25137440
SN - 0269-3879
VL - 29
SP - 523
EP - 528
JO - Biomedical Chromatography
JF - Biomedical Chromatography
IS - 4
ER -